527 related articles for article (PubMed ID: 30871132)
1. Thinking Outside the Bug: Molecular Targets and Strategies to Overcome Antibiotic Resistance.
Monserrat-Martinez A; Gambin Y; Sierecki E
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871132
[TBL] [Abstract][Full Text] [Related]
2. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.
Eliopoulos GM
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):826-31. PubMed ID: 16315008
[TBL] [Abstract][Full Text] [Related]
4. [Gram positive multi-drug resistance: what probability and fear?].
Lina G; Cattoir V
Bull Acad Natl Med; 2014 Mar; 198(3):427-38; discussion 438. PubMed ID: 26427288
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Michel M; Gutmann L
Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
[TBL] [Abstract][Full Text] [Related]
6. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.
Schentag JJ; Hyatt JM; Carr JR; Paladino JA; Birmingham MC; Zimmer GS; Cumbo TJ
Clin Infect Dis; 1998 May; 26(5):1204-14. PubMed ID: 9597254
[TBL] [Abstract][Full Text] [Related]
7. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
Socha AM; LaPlante KL; Rowley DC
Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
[TBL] [Abstract][Full Text] [Related]
8. [Update of antimicrobial resistance in Gram-positive microorganisms].
Cercenado E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
[TBL] [Abstract][Full Text] [Related]
9. Naturally-Occurring Alkaloids of Plant Origin as Potential Antimicrobials against Antibiotic-Resistant Infections.
Casciaro B; Mangiardi L; Cappiello F; Romeo I; Loffredo MR; Iazzetti A; Calcaterra A; Goggiamani A; Ghirga F; Mangoni ML; Botta B; Quaglio D
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784887
[TBL] [Abstract][Full Text] [Related]
10. Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
Eom SH; Kim YM; Kim SK
Appl Microbiol Biotechnol; 2013 Jun; 97(11):4763-73. PubMed ID: 23640363
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
12. [Gram-positive bacterial infections resistant to antibiotic treatment].
Utili R
Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
[TBL] [Abstract][Full Text] [Related]
13. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of gram-positive cocci infections and drug resistance.
Li G; Hou S; Li Y; Liu S; Teng D; Hou D
Cell Mol Biol (Noisy-le-grand); 2015 Sep; 61(4):90-3. PubMed ID: 26386666
[TBL] [Abstract][Full Text] [Related]
15. Management of antibiotic resistance in the intensive care unit setting.
Petrosillo N; Capone A; Di Bella S; Taglietti F
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
[TBL] [Abstract][Full Text] [Related]
16. The 'H-Bug' epidemic: lessons from antibiotic-resistant staphylococcal outbreaks in New Zealand hospitals from 1955-1963.
Jowitt D
N Z Med J; 2019 Sep; 132(1502):84-95. PubMed ID: 31563930
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin in bone and joint infections: a review of the literature.
Rice DA; Mendez-Vigo L
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
[TBL] [Abstract][Full Text] [Related]
18. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
van Harten RM; Willems RJL; Martin NI; Hendrickx APA
Trends Microbiol; 2017 Jun; 25(6):467-479. PubMed ID: 28209400
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Bogomolova NS; Bol'shakov LV; Kuznetsova SM; Oreshkina TD
Antibiot Khimioter; 2011; 56(5-6):37-45. PubMed ID: 22145229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
